MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(
Call Girls Aurangabad Just Call 9907093804 Top Class Call Girl Service Available
MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)
1. Here is where your presentation begins
ABO & RH
BLOOD
GROUP
2. ABO SYSTEM
Discovered by Karl Landsteiner in 1901
The ABO system is the most important of all blood groups in transfusion medicine.
ABO gene is located in “chromosome 9”
3. Found on RBCs, lymphocytes, platelets, tissue cells, bone marrow and other
organs.
Developed in utero 5-6 weeks gestation; full expression occurs between 2-4 years
of age.
Formation of ABO antigens:
ABO Antigen
Gene Glucosyltransferases Immunodominant
Sugar
Antigen
H a-2-L-fucosyltransferase L-fucose H
A a-3-N- acetylgalactosaminyltransferase N-acetyl-D-
galactosamine
A
B A-3-D-galactosyltransferase D-galactose B
4.
5. ABO Antibodies
Naturally occurring; predominantly IgM
Production initiated at birth
Detectable titers: 3-6 months, peaks at 5-10 years
Blood Group Antibody produced Characteristics
A Anti-B IgM
• Naturally occurring
• React at room
temperature
• Cannot cross placenta
B Anti-A
AB --- ---
O Anti-A
Anti-B
Mostly IgM (some IgG)
6. Forward Grouping
-Using known sources of commercial anti-sera to detect antigens on an individual’s
RBC
Blood Group Antigen Reaction with Interpretation
Anti-A Anti-B Anti-A,B
A A + - + A
B B - + + B
AB AB + + + AB
O NONE - - - O
7. Reverse Grouping
-Using reagent cells with known A and B antigens and testing the serum of the patient
for ABO group antibodies
Blood Group Antibody Reaction with Interpretation
A cells B cells
A Anti-B - + A
B Anti-A + - B
AB NONE - - AB
O Anti A & Anti B + + O
8. ABO Discrepancies
1. Group I Discrepancies
2. Group II Discrepancies
3. Group III Discrepancies
4. Group IV Discrepancies
9. Group I Discrepancies
-Associated with unexpected reaction in reverse grouping due to weakly reacting or
missing antibodies.
• Newborns
• Patients with Leukemia
• Patients with congenital or acquired agammagloblulinemia or immunodeficiency
disease
• Elderly patients
• Patients with bone marrow or stem cell transplantations
10. Group II
-Associated with unexpected reactions in the forward grouping due to weakly reacting
or missing antigens.
• Subgroups of A and/or B
• Leukemia
• Hodgkin’s disease
• Acquired B
11. Group III
-These discrepancies between forward and reverse groupings are caused by protein or
plasma abnormalities and result in rouleaux formation or pseudoagglutination,
attributable to:
• Elevated levels of globin
• Elevated levels of fibrinogen
• Plasma expanders
• Wharton’s Jelly
12. Group IV
-These discrepancies between forward and reverse groupings are due to
miscellaneous problems and have the following causes:
• Presence of cold reactive autoantibodies
• Unexpected ABO isoagglutinins
• Unexpected non-ABO alloantibodies
• Cis-AB phenomenon
13. Rh SYSTEM
Rhesus Blood Group System
It is the primary cause of HDFN and significant cause of HTR
RH gene located on short arm of chromosome 1
14. Rh Antigens
• Rh antigens are highly immunogenic, the D antigen is most potent
• Well developed at birth
• Exposure to 1ml of Rh positive red cells can stimulate Ab production in an Rh
negative person
15. Rh Antibody
• Most Rh antibodies are IgG, produced through pregnancy and incompatible
transfusions
• Causes HTR and HDFN
Rh Typing
1. Slide typing
• Rapid method; reagent: anti-D antiserum
• Positive test: Agglutination visible within 2 minutes
2. Tube typing
• For differentiating Rh negative (absence of D antigen) from weak D
• Method: INDIRECT ANTIGLOBULIN TEST
Patient RBC + anti-D -> wash RBC -> add AHG
16. Nomenclature of Rh System
1. Fisher-Race (DCE)
2. Wiener (Rh-Hr)
3. Rosenfield (Alpha-Numeric)
4. International Society of Blood Transfusion (ISBT): Numeric Terminology
17. Fisher-Race (DCE)
• Most commonly used (i.e. WHO)
• They theorized that Rh antigens are controlled by a complex of 3 sets of genes with
closely linked loci
18. Wiener (Rh-Hr)
• Rh-Hr Terminology
• Rarely used, but good for describing phenotype
• A single gene at the Rh locus leads at the expression of Rh antigens
• Each gene controls production of an agglutinogen composed of three factors
(antigens)
20. ISBT: NUMERICAL TERMINOLOGY
• To establish a uniform nomenclature that is both a eye and machine-readable
• Adaptation of six-digit number of each identical antigen belonging to a blood group
21. WEAK D
• Occurs when D is weakly expressed; more common in blacks
4 Mechanisms of weakened expression of D antigen
1. Genetic cause
2. Position effect or C in Trans
3. Partial D or D mosaic
4. Del